Testing effectiveness (Phase 2)Looking for participantsNCT07017673
What this trial is testing
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Who this might be right for
TNBCTNBC - Triple-Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Cedars-Sinai Medical Center 34